EC Pharmacology and Toxicology

Traditional drug design in pharmacology and toxicology has long been dominated by the classic organic lock-and-key paradigm, which primarily focuses on localized, three-dimensional steric matching between a ligand and a receptor. However, this empirical view often overlooks the macro-geometric and mathematical constraints governing the environment of living systems. Biological targets, such as functional proteins, receptors, enzymes, and DNA, are not merely chiral molecules; they constitute highly restricted, non-centrosymmetric mathematical spaces. From a crystallographic perspective, because all terrestrial proteins are constructed exclusively from L-amino acids and nucleic acids from D-sugars, biological macromolecular systems inherently obey a strict geometric rule: they crystallize exclusively within the 65 Sohncke space groups. These 65 groups represent the subset of all 230 space groups that completely lack operations of the second kind, such as inversion centers, mirror planes, and improper rotations, being composed solely of operations of the first kind like rotations and translations. Crucially, a frequent misconception in stereopharmacology is that chiral biomolecules or isolated enantiomeric drugs must belong to the more restrictive 22 chiral space groups. In reality, nature universally utilizes the broader 65 Sohncke groups, demonstrating that the exclusion of mirror symmetry, rather than the explicit handedness of screw axes, is the fundamental mathematical prerequisite of life.

 To establish a rigorous framework, we must clearly delineate the hierarchical concepts of chiral crystallization (spontaneous symmetry breaking of achiral components), spontaneous resolution (physical separation of racemates without external chiral agents), and the long-debated distinction between Sohncke (65 types) and chiral (22 types) space groups. While all chiral structures must crystallize within the 65 Sohncke groups, only 22 of these types possess inherently chiral group structures forming enantiomorphous pairs. The remaining 43 Sohncke groups contain symmetry elements without intrinsic structural handedness, yet they perfectly accommodate pure enantiomeric molecules.

 In our investigation of chiral salen-type iron(III) complexes derived from 1,2-diphenylethylenediamine [1], we encountered the notorious obstacle of ligand racemization during thermal synthesis, which typically yields centrosymmetric, racemic crystals belonging to the achiral space group P1̅. However, by strategically replacing the iron source with FeCl₃ and optimizing microwave-assisted coordination, we achieved a significant breakthrough: the complex successfully underwent spontaneous resolution, isolating the pure optically active S,S-isomer form within the Sohncke space group P2₁. Crystallographic analysis revealed that this chiral packing was driven not merely by the asymmetric carbons of the ligand, but by a robust, extended intermolecular hydrogen-bonding network mediated by the axial water ligand and the aldehyde oxygen atoms of adjacent complex molecules. The local molecular chirality was effectively translated and amplified into the mathematical order of a Sohncke lattice via coordination chemistry.

 This crystallographic truth directly addresses a fundamental question in pharmacology: Is the presence of a mirror-image enantiomer, or a racemic mixture, necessary or beneficial for a pharmaceutical agent? The mathematical answer is a resounding no; furthermore, the mirror-image partner is frequently highly toxic. Because the biological target is a homochiral matrix composed solely of L-amino acids, the receptor pocket represents a strictly biased Sohncke space. When a racemic drug is administered, only the enantiomer whose topological point group matches the target's geometric gradient can achieve the optimal Gibbs free energy of binding triggering the desired therapeutic response as an on-target effect. Conversely, the excess mirror-image partner molecule cannot fit the asymmetric pocket. Deprived of its geometric target, this unwanted enantiomer tends to form non-specific, centrosymmetric-like stackings with other achiral or hydrophilic biological interfaces, leading to severe off-target toxicities, a mechanism tragically epitomized by the thalidomide disaster. Therefore, medicine demands the absolute elimination of the mirror-image partner. However, maintaining pure molecular chirality in a vial is insufficient if the molecule lacks the propensity to arrange itself correctly at the biological interface. The true requirement for a next-generation ligand is the capacity to align harmoniously within the target's Sohncke space. As demonstrated by our P2₁ salen-iron complex, the utilization of transition metals introduces highly tunable coordination geometries, such as octahedral and square planar, and accessible axial coordination sites that are completely unavailable to rigid organic molecules. When a metal complex approaches a protein interface, its axial ligands and dynamic coordination sphere allow it to map fluidly onto the hydrogen-bonding networks of the receptor's water jacket. It is this collective, space-group-level synchronization between the ligand assembly and the protein's Sohncke topography that minimizes entropy and maximizes binding specificity.

 The beauty of an inorganic crystal structure is the physical manifestation of geometry optimized by nature for thermodynamic stability. For decades, pharmacology and toxicology have relied on empirical trial-and-error high-throughput screenings. By introducing the mathematical rigor of group theory and Sohncke space group assemblies into the fluid complexity of life sciences, we can transform stereopharmacology into a predictable geometric science. In the homochiral, non-centrosymmetric reality of living systems, forcing a drug to travel with its mirror-image partner is nothing short of a toxic mismatch. Our goal must shift from replicating molecular chirality to precisely controlling symmetry breaking and subsequent packing dynamics at the bio-interface. Embracing the elegant, mathematical order of coordination networks will serve as the definitive cipher to unlock safe, rational, accurate, and beautiful molecular therapeutics for the future.

Disclosure

The author declares no competing financial interests or conflicts of interest regarding the publication of this manuscript.

1. Iwatani I., et al. “Chiral behavior and racemization of Salen-type ligands and their iron complexes: An x-ray crystal structure study”. Crystals 7 (2026): 465-475.